1st Quarter - Report

CAPITOL SOLUTIONS for AMGEN USA

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1956, Patient Protection and Innovative Biologics Medicines Act of 2007 H.R. 1038, Access to Life-saving Medicines Act H.R. 5629, Pathway for Biosimilars Act

LobbyistCovered position, as disclosed
SARAH CURTIS Legislative Assistant, Rep. Strickland
DANIEL C TATE Legislative Assistant, Rep. W.J. Billy Tauzin

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5629 (110th), H.R. 1956 (110th), H.R. 1038 (110th)

Medicare/Medicaid MMM

Medicare reimbursement and coverage issues

LobbyistCovered position, as disclosed
SARAH CURTIS Legislative Assistant, Rep. Strickland
DANIEL C TATE Legislative Assitant, Rep. W.J. Billy Tauzin

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.